SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Samrat Pharmachem

BSE: 530125|ISIN: INE103E01016|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Sep 27, 10:58
39.25
2.2 (5.94%)
VOLUME 1,508
Samrat Pharmachem is not listed on NSE
Announcements on Samrat Pharma

26th-Sep-2016 20:00Source: BSE

Samrat Pharma- Outcome of AGM

Samrat Pharmachem Ltd has informed BSE that the 24th Annual General Meeting (AGM) of the Company was held on September 26, 2016.

16th-Sep-2016 15:23Source: BSE

Samrat Pharma- Addendum to the Notice of 24th Annual General Meeting

Samrat Pharmachem Ltd has informed BSE regarding Addendum to the Notice of 24th Annual General Meeting of the Company.

16th-Sep-2016 14:49Source: BSE

Samrat Pharma- Change in Statutory Auditors

Samrat Pharmachem Ltd has informed BSE regarding Change in Statutory Auditors of the Company.

2nd-Sep-2016 15:07Source: BSE

Samrat Pharma- Form A for March 31, 2016

Samrat Pharmachem Ltd has informed BSE about :

1. Standalone Form A for the period ended March 31, 2016

2nd-Sep-2016 12:24Source: BSE

Samrat Pharma- Fixes Book Closure for AGM

Samrat Pharmachem Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 10, 2016 to September 24, 2016 (both days inclusive) for the...

12th-Aug-2016 19:19Source: BSE

Samrat Pharma- Standalone Financial Results, Limited Review Report for June 30, 2016

Samrat Pharmachem Ltd has informed BSE about :

1. Standalone Financial Results for the period ended June 30, 2016

2. Standalone Limited Review for the period ended June 30, 2016

16th-Jul-2016 12:15Source: BSE

Samrat Pharma- Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended June 30, 2016

Samrat Pharmachem Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended June 30, 2016, under Regulation 13(3) of SEBI (Listin...

2nd-Jun-2016 18:28Source: BSE

Samrat Pharma- Standalone Financial Results, Auditors Report for March 31, 2016

Samrat Pharmachem Ltd has informed BSE about :

1. Standalone Financial Results for the period ended March 31, 2016

2. Standalone Auditors Report for the period ended March 31, 2016

15th-Apr-2016 15:26Source: BSE

Samrat Pharma- Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended March 31, 2016

Samrat Pharmachem Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listi...

14th-Apr-2016 19:06Source: BSE

Samrat Pharma- Shareholding for the Period Ended March 31, 2016

Samrat Pharmachem Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2016. For more details, kindly

Quick Links for Samrat Pharmachem
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.